PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | C0021390|inflammatory bowel disease |
| Sentences | 5 |
| PubMedID- 25052345 | Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-tnf therapies: multicenter prospective observational study (repentina 3). |
| PubMedID- 23891915 | Efficacy and safety of treatment of hepatitis c in patients with inflammatory bowel disease. |
| PubMedID- 20688604 | Background: data on the prevalence of hepatitis c in patients with inflammatory bowel diseases (ibd) are limited and conflicting. |
| PubMedID- 23179145 | The influence of anti-tnf therapy on the course of chronic hepatitis c virus infection in patients with inflammatory bowel disease. |
| PubMedID- 22464811 | Background: the prevalence rates of hepatitis b virus (hbv) and hepatitis c virus (hcv) in patients with inflammatory bowel disease (ibd) have been reported to be higher than rates of infection among the general population. |
Page: 1